PRODUCT USE IN UNAPPROVED INDICATION

This adverse event was reported 233856 times

These drugs are most commonly taken by patients reporting PRODUCT USE IN UNAPPROVED INDICATION:

# Drug Count
0 DUPILUMAB 38078
1 DICLOFENAC SODIUM 13047
2 PREDNISONE 12727
3 METHOTREXATE SODIUM 10536
4 ACETAMINOPHEN 9822
5 METHOTREXATE 9811
6 RITUXIMAB 7616
7 GABAPENTIN 7585
8 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 7193
9 MYCOPHENOLATE MOFETIL 7173
See all common drugs associated with PRODUCT USE IN UNAPPROVED INDICATION

PRODUCT USE IN UNAPPROVED INDICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBUPROFEN, ACETAMINOPHEN 1717 0.6203
1 METHOXSALEN 336 0.4492
2 CAPLACIZUMAB 522 0.3187
3 ALMOTRIPTAN 302 0.3166
4 OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE 603 0.3120
5 IBUPROFEN, PHENYLEPHRINE HYDROCHLORIDE 289 0.2905
6 DUVELISIB 178 0.2348
7 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 138 0.2273
8 ETHIODIZED OIL 284 0.2261
9 CAFFEINE CITRATE 446 0.2044
See all drugs enriched for association with PRODUCT USE IN UNAPPROVED INDICATION

PRODUCT USE IN UNAPPROVED INDICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoactivated Radical Generator [EPC] 336 0.4492
1 Menin Inhibitor [EPC] 2 0.1053
2 Interleukin-4 Receptor alpha Antagonist [EPC] 38078 0.0868
3 Anthelmintic [EPC] 246 0.0866
4 Antiparasitic [EPC] 461 0.0756
5 Pediculicide [EPC] 464 0.0700
6 Antileishmanial [EPC] 26 0.0699
7 Polyene Antimicrobial [EPC] 26 0.0682
8 Prostacyclin Receptor Agonist [EPC] 183 0.0662
9 Melanin Synthesis Inhibitor [EPC] 73 0.0658
See all drug classes enriched for association with PRODUCT USE IN UNAPPROVED INDICATION